{
    "organizations": [],
    "uuid": "dda695a3943c76a496fbb4aacade36e4468fbeb3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-novo-nordisk-ceo-we-remain-committ/brief-novo-nordisk-ceo-we-remain-committed-to-grow-in-biopharma-segment-also-via-acquisitions-idUSC7N1JW00Z",
    "ord_in_thread": 0,
    "title": "BRIEF-Novo Nordisk CEO: We Remain Committed To Grow In Biopharma Segment, Also Via Acquisitions",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 1 (Reuters) - Novo Nordisk A/S:\n* NOVO NORDISK CEO SAYS WE REMAIN COMMITTED TO GROWTH IN THE BIOPHARMA SEGMENT, ALSO VIA ACQUISITIONS Further company coverage: (Reporting by Jacob Gr√∏nholt-Pedersen)\n ",
    "published": "2018-02-01T18:26:00.000+02:00",
    "crawled": "2018-02-02T13:11:02.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "novo",
        "nordisk",
        "novo",
        "nordisk",
        "ceo",
        "say",
        "remain",
        "committed",
        "growth",
        "biopharma",
        "segment",
        "also",
        "via",
        "acquisition",
        "company",
        "coverage",
        "reporting",
        "jacob"
    ]
}